Myovant Sciences
-$0.17 (-0.87%) Today
+$0.01 (+0.05%) As of 11:00 AM UTC after-hours
Why Robinhood?
You can buy or sell MYOV and other stocks, options, and ETFs commission-free!
About MYOV
Myovant Sciences Ltd., also called Myovant Sciences, is a clinical-stage biopharmaceutical company. It focuses on developing and commercializing therapies for the treatment of women's health and endocrine diseases.
CEO
David C. Marek
Employees
214
Headquarters
London, Greater London
Founded
2016
MYOV Key Statistics
Market Cap
1.85B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
576.21K
High Today
$19.68
Low Today
$18.80
Open Price
$19.28
Volume
390.05K
52 Week High
$30.90
52 Week Low
$11.55
Analyst Ratings
71%
of 7 ratings
Buy
71.4%
Hold
28.6%
Sell
0%
MYOV Earnings
-$0.99
-$0.66
-$0.33
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
-$0.99 per share
Actual
Available May 11, Pre-Market